Bluejay Diagnostics reports $5.2 million cash, plans $20 million fundraising Mar 6, 2026 06:42AM
Bluejay Diagnostics completes prefunded warrant exercises Feb 20, 2026 06:31AM
Bluejay Diagnostics completes commercial-scale IL-6 antibody production Dec 29, 2025 07:00AM
Bluejay Diagnostics reports 50% enrollment in sepsis trial Nov 10, 2025 07:30AM
bluejay Diagnostics (BJDX) Provides Mid-Year Business and Corporate Update Jun 3, 2025 04:08PM


Dec 5, 2024 07:16AM bluejay Diagnostics (BJDX) regained compliance with Nasdaq Listing Rule
Jun 27, 2024 08:59AM bluejay Diagnostics (BJDX) Prices 5.37M Share Offering at $1.63/sh
Jun 26, 2024 08:04AM bluejay Diagnostics (BJDX): SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
Jun 17, 2024 08:01AM bluejay Diagnostics (BJDX) Announces 1:8 Reverse Share Split